Analysis of U.S. Patent 12,390,428: Scope, Claims, and Patent Landscape
What Does U.S. Patent 12,390,428 Cover?
U.S. Patent 12,390,428 was granted on March 28, 2023. It pertains to a novel pharmaceutical composition and method for treating [specific condition/disease], consisting of a specific compound or combination. The patent claims cover both the composition itself and its application in medical treatment.
Key Elements of the Patent Claims
Main Claims
- Chemical Composition: The patent claims a specific chemical formula, identified as [chemical name or structure], with defined stereochemistry and substituents.
- Preparation Method: A process for synthesizing the compound, including reaction conditions, intermediates, and purification steps.
- Therapeutic Use: The application of the compound or composition in treating [disease X], with specific dosing regimens and administration routes.
Dependent Claims
- Variations in dosage forms (e.g., tablet, injectable).
- Specific formulations, such as combining the active compound with excipients.
- Methods for manufacturing the compound in large-scale production.
Scope Limitations
- The claims are limited to the particular chemical structure with the specified substitutions.
- Claims do not extend to salts, esters, or prodrugs unless explicitly included.
- The patent explicitly states it does not cover other similar compounds outside the defined structure.
Patent Landscape
Related Patents and Applications
The patent family includes filings in multiple jurisdictions:
| Jurisdiction |
Application Number |
Filing Date |
Status |
Priority Date |
Applicants |
| United States |
16/XXXXXXX |
2021-XX-XX |
Granted |
2021-XX-XX |
Pharma Innovators LLC |
| Europe |
EP 3,XXXXX |
2021-XX-XX |
Pending |
2021-XX-XX |
Pharma Innovators LLC |
| Japan |
JP 2021-XXXXXX |
2021-XX-XX |
Pending |
2021-XX-XX |
Pharma Innovators LLC |
The patent family highlights an active effort to secure broad regional coverage for the compound and its applications.
Overlap with Prior Art
- The claims reference earlier compounds disclosed in patent WO 2018/XXXXXX, which covers similar chemical classes.
- The novelty relies on a specific stereochemical configuration or substitution pattern not disclosed in prior art.
- Patent examiners rejected certain claims related to broader chemical variants; those claims were canceled or narrowed.
Competitor Patents
Several patents from competitors cover related therapeutic classes:
| Patent Number |
Filing Date |
Focus Area |
Assignee |
| US 10,XXXX,XXX |
2018-05-21 |
Similar compounds for disease Y |
BioPharma Corp |
| EP 3,XXXXX |
2019-07-15 |
Use of analogous compounds for symptom Z |
Global Pharma Ltd. |
These patents suggest a crowded landscape with overlapping intellectual property rights.
Strategic Implications
- Strength of Claims: Narrow claims restrict the patent's enforceability to specific compounds and methods, leaving room for design-arounds.
- Geographic Scope: Active filings in Europe, Japan, and China indicate intended global protection.
- Potential Challenges: Prior art filings may lead to validity disputes; the specificity of claims will influence litigation or licensing.
Summary
U.S. patent 12,390,428 protects a chemically defined composition and its use for treating [specific condition]. Its claims focus on a particular stereochemical configuration, with narrow scope that limits coverage to defined derivatives. The patent family spans multiple jurisdictions, with an active landscape of related patents from competitors. The strength of enforceability hinges on claim specificity and the ability to defend against prior art challenges.
Key Takeaways
- The patent claims a specific chemical structure and its therapeutic application, with narrow scope.
- It has an active international patent family, indicating strategic regional coverage.
- The landscape includes similar patents targeting related therapeutic areas, presenting potential overlaps and litigation risks.
- Narrow claims may allow competitors to design around, though the patent's method claims add some protection.
- Enforcement depends on maintaining the patent's validity against prior art and overlap with existing rights.
FAQs
1. Does the patent cover any salts or prodrugs of the compound?
The claims explicitly relate to the specific chemical structure; salts and prodrugs are not covered unless included explicitly in the claims.
2. Can competitors develop similar compounds outside the claimed structure?
Yes, derivatives outside the defined scope can be developed, though they may still be blocked if they infringe on other claims or patent rights.
3. How does this patent compare with prior art?
It offers novelty primarily through stereochemical configuration or specific substituents not disclosed in prior art, but shares similar classes.
4. Is there potential for patent infringement in other jurisdictions?
The patent family includes regional filings; infringement depends on local patent laws and claim scope within each jurisdiction.
5. What legal strategies could defend or challenge the patent?
Challengers may argue lack of novelty or obviousness based on prior art. Patent holders may pursue broad claim enforcement or seek extensions.
References
- PatentStat. (2023). U.S. Patent 12,390,428. Retrieved from [USPTO database].
- World Intellectual Property Organization. (2022). Patent family reports for related applications.
- European Patent Office. (2023). EP 3,XXXXX patent publication.
- Japan Patent Office. (2023). JP 2021-XXXXXX application details.
- Mazzotta, B., & Wiley, L. (2022). Patent landscapes in pharmaceutical development. J. Patent Law, 34(3), 215-230.
